From first in man transcatheter aortic valve implantation, a 15-year experience.

Back

ESC Premium Access

From first in man transcatheter aortic valve implantation, a 15-year experience.

Session: 15 years of TAVI: increasing evidence for routine use

Topic: Intervention

Speaker: Doctor G. Avinee (Rouen, FR)

Event: ESC Congress 2019

Congress Presentation

About the speaker

Doctor Guillaume Avinee

Rouen University Hospital, FHU Remod-VHF, Rouen (France)

0 follower

3 more presentations in this session

State of the Art - Current evidence and future perspectives of TAVI

Speaker: Professor H. Baumgartner (Muenster, DE)

Access

Slides

Video

Clinical impact of mitral regurgitation before or following transcatheter aortic valve replacement in patients with aortic stenosis: a nationwide multivariable analysis

Speaker: Professor L. Fauchier (Tours, FR)

Early changes in quality of life after transcatheter aortic valve replacement: One-year results from the 3M TAVR Study

Speaker: Doctor S. Lauck (Vancouver, CA)

Access the full session

15 years of TAVI: increasing evidence for routine use

Speakers: Doctor G. Avinee, Professor H. Baumgartner, Professor L. Fauchier, Doctor S. Lauck

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

From first in man transcatheter aortic valve implantation, a 15-year experience.

About the speaker

Doctor Guillaume Avinee

3 more presentations in this session

State of the Art - Current evidence and future perspectives of TAVI

Clinical impact of mitral regurgitation before or following transcatheter aortic valve replacement in patients with aortic stenosis: a nationwide multivariable analysis

Early changes in quality of life after transcatheter aortic valve replacement: One-year results from the 3M TAVR Study

Access the full session

15 years of TAVI: increasing evidence for routine use

About the event

ESC Congress 2019

ESC 365 is supported by